Relias V[Author] - Search Results

Year	Number of Results
1985	2
1988	2
1990	1
1991	1
1992	1
1993	1
1994	1
2000	1
2004	1
2006	1
2008	2
2009	2
2013	1
2014	4
2015	1
2016	1
2017	1
2018	1
2019	2
2020	3
2021	2
2022	0

1

BRCA and pancreatic cancer.

Brennan GT, Relias V, Saif MW. Brennan GT, et al. Among authors: relias v. JOP. 2013 Jul 10;14(4):325-8. doi: 10.6092/1590-8577/1652. JOP. 2013. PMID: 23846919 Free article. Review.

2

Management of regorafenib-related toxicities: a review.

Krishnamoorthy SK, Relias V, Sebastian S, Jayaraman V, Saif MW. Krishnamoorthy SK, et al. Among authors: relias v. Therap Adv Gastroenterol. 2015 Sep;8(5):285-97. doi: 10.1177/1756283X15580743. Therap Adv Gastroenterol. 2015. PMID: 26327919 Free PMC article. Review.

3

Safety and Efficacy of Same-Day Administration of Pegfilgrastim in Patients Receiving Chemotherapy for Gastrointestinal Malignancies.

Matera RM, Relias V, Saif MW. Matera RM, et al. Among authors: relias v. Cancer Med J. 2021 Apr 1;4(1):6-11. Epub 2020 May 18. Cancer Med J. 2021. PMID: 32656544 Free PMC article.

4

Incidence and management of ZIv-aflibercept related toxicities in colorectal cancer.

Saif MW, Relias V, Syrigos K, Gunturu KS. Saif MW, et al. Among authors: relias v. World J Clin Oncol. 2014 Dec 10;5(5):1028-35. doi: 10.5306/wjco.v5.i5.1028. World J Clin Oncol. 2014. PMID: 25493238 Free PMC article. Review.

5

Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacists.

Relias V, McBride A, Newman MJ, Paul S, Saneeymehri S, Stanislaus G, Tobin J, Hoang CJ, Ryan JC, Galinsky I. Relias V, et al. J Oncol Pharm Pract. 2021 Apr;27(3):658-672. doi: 10.1177/1078155220973737. Epub 2020 Nov 20. J Oncol Pharm Pract. 2021. PMID: 33215562 Free PMC article. Clinical Trial.

6

Biological identification of ampullary adenocarcinomas.

Relias V, Saif MW. Relias V, et al. JOP. 2014 Jul 28;15(4):306-7. doi: 10.6092/1590-8577/2674. JOP. 2014. PMID: 25076327 Free article.

7

Novel agents for the treatment of pancreatic cancer.

Brennan GT, Relias V, Saif MW. Brennan GT, et al. Among authors: relias v. JOP. 2014 Mar 10;15(2):110-3. doi: 10.6092/1590-8577/2320. JOP. 2014. PMID: 24618430 Free article.

8

Racial Differences in Accepting Pegfilgrastim Onpro Kit (On-Body Injector) Use Among Cancer Patients.

Saif MW, Hackenyos DW, Smith MH, Healey P, Relias V, Wasif K. Saif MW, et al. Among authors: relias v. Clin Oncol (Las Vegas). 2019;1(6):1026. Epub 2019 Feb 25. Clin Oncol (Las Vegas). 2019. PMID: 31406963 Free PMC article.

9

Chronic Use of Long-Acting Somatostatin Analogues (SSAs) and Exocrine Pancreatic Insufficiency (EPI) in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): An Under-recognized Adverse Effect.

Saif MW, Romano A, Smith MH, Patel R, Relias V. Saif MW, et al. Among authors: relias v. Cancer Med J. 2020;3(2):75-84. Epub 2020 Apr 27. Cancer Med J. 2020. PMID: 32405630 Free PMC article.

10

Treatment with Lanreotide Depot Following Octreotide Long-Acting Release Among Patients with Gastroenteropancreatic Neuroendocrine Tumors.

Saif MW, Fu J, Smith MH, Weinstein B, Relias V, Daly KP. Saif MW, et al. Among authors: relias v. J Pancreat Cancer. 2018 Oct 1;4(1):64-71. doi: 10.1089/pancan.2018.0013. eCollection 2018. J Pancreat Cancer. 2018. PMID: 30788459 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results